Published in J Virol on November 01, 2004
Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry. J Virol (2006) 1.64
Synthesis and characterization of biodegradable HPMA-oligolysine copolymers for improved gene delivery. Bioconjug Chem (2010) 1.05
Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol. Sci Rep (2014) 0.92
Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset. J Virol (2007) 0.91
Two dimensional VOPBA reveals laminin receptor (LAMR1) interaction with dengue virus serotypes 1, 2 and 3. Virol J (2005) 0.87
Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures. Antimicrob Agents Chemother (2014) 0.83
Determinants of the specificity of rotavirus interactions with the alpha2beta1 integrin. J Biol Chem (2010) 0.80
Relative roles of GM1 ganglioside, N-acylneuraminic acids, and α2β1 integrin in mediating rotavirus infection. J Virol (2014) 0.79
Identification of Equine Lactadherin-derived Peptides That Inhibit Rotavirus Infection via Integrin Receptor Competition. J Biol Chem (2015) 0.77
Integrins: bidirectional, allosteric signaling machines. Cell (2002) 36.25
Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem (1987) 10.61
Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87
Structural basis of collagen recognition by integrin alpha2beta1. Cell (2000) 4.84
Structural polypeptides of simian rotavirus SA11 and the effect of trypsin. J Virol (1981) 3.27
Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates. J Virol (1985) 2.81
Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol (1994) 2.48
The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J (2002) 2.41
Trypsin enhancement of rotavirus infectivity: mechanism of enhancement. J Virol (1981) 2.29
Three-dimensional structure of the rotavirus haemagglutinin VP4 by cryo-electron microscopy and difference map analysis. EMBO J (1994) 1.90
Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells. Proc Natl Acad Sci U S A (1997) 1.82
Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem (1991) 1.79
Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells. J Virol (2000) 1.72
Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell adsorption. Virology (1989) 1.71
Multistep entry of rotavirus into cells: a Versaillesque dance. Trends Microbiol (2004) 1.62
Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J Virol (1996) 1.56
Integrin alpha(v)beta(3) mediates rotavirus cell entry. Proc Natl Acad Sci U S A (2000) 1.56
Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry. J Virol (2003) 1.56
Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J Virol (2001) 1.51
Identification in collagen type I of an integrin alpha2 beta1-binding site containing an essential GER sequence. J Biol Chem (1998) 1.51
Identification and partial characterization of a rhesus rotavirus binding glycoprotein on murine enterocytes. Virology (1991) 1.50
Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol (2002) 1.42
Structure and function of a ganglioside receptor for porcine rotavirus. J Virol (1998) 1.39
Localization of membrane permeabilization and receptor binding sites on the VP4 hemagglutinin of rotavirus: implications for cell entry. J Mol Biol (2001) 1.38
Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype. J Virol (1991) 1.34
Ganglioside GM(1a) on the cell surface is involved in the infection by human rotavirus KUN and MO strains. J Biochem (1999) 1.27
Multiple functional forms of the integrin VLA-2 can be derived from a single alpha 2 cDNA clone: interconversion of forms induced by an anti-beta 1 antibody. J Cell Biol (1993) 1.26
Reciprocal signaling by integrin and nonintegrin receptors during collagen activation of platelets. Mol Cell Biol (2003) 1.18
Integrin alpha2beta1 mediates the cell attachment of the rotavirus neuraminidase-resistant variant nar3. Virology (2000) 1.16
Integrin alpha(2)beta(1) (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue. Blood (2000) 1.15
New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat Med (2000) 1.15
Mechanisms of integrin-mediated virus attachment and internalization process. Crit Rev Immunol (2001) 1.15
VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J Virol (2002) 1.10
Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro. Biochem Pharmacol (1991) 1.08
Rotavirus infection of MA104 cells is inhibited by Ricinus lectin and separately expressed single binding domains. Virology (2000) 1.01
Growth of rotaviruses in continuous human and monkey cell lines that vary in their expression of integrins. J Gen Virol (2000) 1.00
Integrins as mediators of epithelial cell-matrix interactions in the human small intestinal mucosa. Microsc Res Tech (2000) 1.00
Expression and functional importance of collagen-binding integrins, alpha 1 beta 1 and alpha 2 beta 1, on virus-activated T cells. J Immunol (2003) 0.98
Attachment and growth of human rotaviruses RV-3 and S12/85 in Caco-2 cells depend on VP4. J Virol (1998) 0.98
Monkey rotavirus binding to alpha2beta1 integrin requires the alpha2 I domain and is facilitated by the homologous beta1 subunit. J Virol (2003) 0.93
Free radical induced polymerization of synthetic peptides into polymeric immunogens. Vaccine (1997) 0.90
Discrete domains within the rotavirus VP5* direct peripheral membrane association and membrane permeability. J Virol (2004) 0.89
Type I collagen influence on gene expression in UMR106-06 osteoblast-like cells is inhibited by genistein. J Endocrinol (1998) 0.86
Synthetic peptide epitope-based polymers: controlling size and determining the efficiency of epitope incorporation. J Pept Res (2002) 0.82
Non-lytic extraction and characterisation of receptors for multiple strains of rotavirus. Arch Virol (2001) 0.81
Inhibition of collagen-induced platelet reactivity by DGEA peptide. Acta Biochim Pol (2003) 0.79
A collagen peptide motif activates tyrosine kinase-dependent calcium signalling pathways in human osteoblast-like cells. Matrix Biol (1997) 0.78
Phorbol dibutyrate-induced megakaryocytic differentiation increases susceptibility of K562 cells to SA11 rotavirus infection. Arch Virol (2001) 0.77
An analysis of Ca2+ release by DGEA: mobilization of two functionally distinct internal stores in Saos-2 cells. Am J Physiol (1998) 0.77
Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature (2002) 3.60
Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging. Nat Chem Biol (2006) 3.22
Inhibition of tissue factor signaling suppresses tumor growth. Blood (2007) 2.16
The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog (2010) 2.03
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2. Proc Natl Acad Sci U S A (2008) 2.00
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc Natl Acad Sci U S A (2004) 1.60
Cross-talk of integrin alpha3beta1 and tissue factor in cell migration. Mol Biol Cell (2004) 1.57
Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry. J Virol (2003) 1.56
Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology (2002) 1.53
T cell epitopes of the La/SSB autoantigen in humanized transgenic mice expressing the HLA class II haplotype DRB1*0301/DQB1*0201. Arthritis Rheum (2007) 1.50
Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions. J Biol Chem (2002) 1.49
Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling. J Biol Chem (2008) 1.40
Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog (2013) 1.39
Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*). J Mol Biol (2007) 1.36
Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides. J Biol Chem (2007) 1.33
Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J Clin Invest (2003) 1.32
Sialic acid dependence in rotavirus host cell invasion. Nat Chem Biol (2008) 1.31
Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines. J Immunol (2002) 1.31
Anti-drug vaccines to treat substance abuse. Immunol Cell Biol (2009) 1.25
Differential regulation of Rho GTPases by beta1 and beta3 integrins: the role of an extracellular domain of integrin in intracellular signaling. J Cell Sci (2002) 1.24
The role of the CPNKEKEC sequence in the beta(2) subunit I domain in regulation of integrin alpha(L)beta(2) (LFA-1). J Immunol (2002) 1.19
Rotavirus activates JNK and p38 signaling pathways in intestinal cells, leading to AP-1-driven transcriptional responses and enhanced virus replication. J Virol (2006) 1.17
Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner. J Biol Chem (2008) 1.16
ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. J Biol Chem (2002) 1.16
Precursor frequency and competition dictate the HLA-A2-restricted CD8+ T cell responses to influenza A infection and vaccination in HLA-A2.1 transgenic mice. J Immunol (2011) 1.13
Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation. Thromb Haemost (2006) 1.12
Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus. J Virol (2002) 1.12
alpha4beta1- and alpha6beta1-integrins are functional receptors for midkine, a heparin-binding growth factor. J Cell Sci (2004) 1.12
The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphavbeta3 is involved in IGF-1 signaling. J Biol Chem (2009) 1.12
Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method. J Med Chem (2009) 1.10
Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza. Eur J Immunol (2006) 1.09
Rotavirus antagonizes cellular antiviral responses by inhibiting the nuclear accumulation of STAT1, STAT2, and NF-kappaB. J Virol (2009) 1.08
Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J Immunol (2009) 1.07
Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. J Biol Chem (2002) 1.07
Direct binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signaling. J Biol Chem (2010) 1.06
Rotaviruses interact with alpha4beta7 and alpha4beta1 integrins by binding the same integrin domains as natural ligands. J Gen Virol (2005) 1.05
Chicken anemia virus VP2 is a novel dual specificity protein phosphatase. J Biol Chem (2002) 1.04
Critical cysteine residues for regulation of integrin alphaIIbbeta3 are clustered in the epidermal growth factor domains of the beta3 subunit. Biochem J (2004) 1.03
Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling. J Biol Chem (2003) 1.03
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals. J Hepatol (2010) 1.02
Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice. Mol Pharm (2012) 1.00
Plasmodium falciparum merozoite surface protein 6 is a dimorphic antigen. Infect Immun (2004) 1.00
Cross-talk between integrin α6β4 and insulin-like growth factor-1 receptor (IGF1R) through direct α6β4 binding to IGF1 and subsequent α6β4-IGF1-IGF1R ternary complex formation in anchorage-independent conditions. J Biol Chem (2012) 0.99
Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J Virol (2008) 0.99
Non-cytotoxic cobra cardiotoxin A5 binds to alpha(v)beta3 integrin and inhibits bone resorption. Identification of cardiotoxins as non-RGD integrin-binding proteins of the Ly-6 family. J Biol Chem (2006) 0.99
Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses. J Immunol (2011) 0.99
Role of integrin alpha(v)beta3 in the early phase of liver metastasis: PET and IVM analyses. Clin Exp Metastasis (2002) 0.99
Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1). J Biol Chem (2004) 0.99
The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth. Cancer Res (2006) 0.98
The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells. J Immunol (2007) 0.97
A partially structured region of a largely unstructured protein, Plasmodium falciparum merozoite surface protein 2 (MSP2), forms amyloid-like fibrils. J Pept Sci (2007) 0.96
Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design. J Pept Sci (2003) 0.95
The use of one-bead one-compound combinatorial library technology to discover high-affinity αvβ3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle. Mol Cancer Ther (2010) 0.95
STD NMR spectroscopy and molecular modeling investigation of the binding of N-acetylneuraminic acid derivatives to rhesus rotavirus VP8* core. Glycobiology (2006) 0.95
Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes. J Immunol (2012) 0.95
Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines. Int Immunol (2006) 0.94
Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus. J Clin Virol (2004) 0.94
Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo. Am J Physiol Gastrointest Liver Physiol (2011) 0.94
Adhesion of gastric carcinoma cells to peritoneum mediated by alpha3beta1 integrin (VLA-3). Cancer Res (2004) 0.94
Monkey rotavirus binding to alpha2beta1 integrin requires the alpha2 I domain and is facilitated by the homologous beta1 subunit. J Virol (2003) 0.93
Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1. J Immunol (2012) 0.93
Lipid-based self-adjuvanting vaccines. Curr Drug Deliv (2005) 0.93
Rotavirus spike protein VP5* binds alpha2beta1 integrin on the cell surface and competes with virus for cell binding and infectivity. J Gen Virol (2006) 0.93
Promiscuous peptide of 16 kDa antigen linked to Pam2Cys protects against Mycobacterium tuberculosis by evoking enduring memory T-cell response. J Infect Dis (2011) 0.92
Lessons from the mouse: potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes. Diabetologia (2015) 0.91
Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset. J Virol (2007) 0.91
Crystallization and preliminary X-ray diffraction analysis of the sialic acid-binding domain (VP8*) of porcine rotavirus strain CRW-8. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.91
A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody. Immunol Cell Biol (2010) 0.91
Model of the alphaLbeta2 integrin I-domain/ICAM-1 DI interface suggests that subtle changes in loop orientation determine ligand specificity. Proteins (2002) 0.89
Novel structural insights into rotavirus recognition of ganglioside glycan receptors. J Mol Biol (2011) 0.89
Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups. Vaccine (2006) 0.89
Innate cellular responses to rotavirus infection. J Gen Virol (2013) 0.88
Enhanced activity of transforming growth factor β1 (TGF-β1) bound to cartilage oligomeric matrix protein. J Biol Chem (2011) 0.88
Lipidated promiscuous peptides vaccine for tuberculosis-endemic regions. Trends Mol Med (2012) 0.88
Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection. J Immunol (2010) 0.88
Attachment of human colon cancer cells to vascular endothelium is enhanced by N-acetylglucosaminyltransferase V. Oncology (2004) 0.87
The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus. Immunol Cell Biol (2012) 0.87
Soluble proteins induce strong CD8+ T cell and antibody responses through electrostatic association with simple cationic or anionic lipopeptides that target TLR2. J Immunol (2011) 0.87